Catalyst Biosciences Inc

NASDAQ:CBIO   3:32:27 PM EDT
0.38
0.00 (+0.76%)
Earnings Announcements

Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results

Published: 05/09/2022 13:49 GMT
Catalyst Biosciences Inc (CBIO) - Catalyst Biosciences Reports First Quarter 2022 Operating & Financial Results.
Q1 Loss per Share $0.46.
Cash and Cash Equivalents As of March 31, 2022, Were $34.8 Million.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.25

More details on our Analysts Page.